SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Announces Investigation of Alliance Financial Corporation (ALNC), Versant Corp. (VSNT) and Class Action Against Vertex Pharmaceuticals Inc.

NEW YORK, Oct. 11, 2012

(Logo:  http://photos.prnewswire.com/prnh/20120409/MM84375LOGO)

Alliance Financial Corporation
Levi & Korsinsky is investigating the Board of Directors of Alliance Financial Corporation (Nasdaq: ALNC) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to NBT Bancorp Inc. (NasdaqGS: NBTB) for approximately $48 per share in NBT stock. At least one analyst set a price target for Alliance stock at $50.00 per share.

Click here to learn more about the investigation: http://zlk.9nl.com/alliance-financial-alnc, or call: 877-363-5972.

Versant Corp.
Levi & Korsinsky is investigating the Board of Directors of Versant Corp. (NASDAQ: VSNT) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to UNICOM Systems, Inc. for $11.50 per share.

Click here to learn more about the investigation: http://zlk.9nl.com/versant-vsnt, or call: 877-363-5972.

Vertex Pharmaceuticals Incorporated
Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the District of Massachusetts on behalf of investors who acquired Vertex Pharmaceuticals Incorporated (NasdaqGS: VRTX) securities between May 7, 2012 and June 27, 2012.